tailieunhanh - Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: Integrated study of three prospective multicenter phase II trials

The efficacy of olanzapine as an antiemetic agent in cancer chemotherapy has been demonstrated. However, few high-quality reports are available on the evaluation of olanzapine’s efficacy and safety at a low dose of 5 mg among patients treated with carboplatin regimens. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN